Gilead Sciences Inc. has announced the appointment of Erin Burkhart as Senior Vice President, Controllership, and principal accounting officer, effective September 22, 2025. Burkhart joins Gilead from BioMarin Pharmaceutical Inc., where she has served as Group Vice President and Chief Accounting Officer since May 2022. She will succeed Diane E. Wilfong, who will step down from her interim role as Controller and principal accounting officer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.